Axogen, Inc.
38.06USD
+1.3800 (+3.76%)
Computing valuation metrics…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on AXGN.
Valuation
P/E (TTM)
—
P/E (Forward)
52.43x
EV/EBITDA
—
EV/Revenue
7.78x
P/S (TTM)
8.89x
P/B
8.71x
FCF Yield
0.39%
Dividend Yield
0.00%
Gross Margin
74.56%
Operating Margin
-5.12%
Net Margin
-13.36%
Peer Comparison — Medical Devices
| Company | Mkt Cap | P/E | EV/EBITDA | FCF Yield | Rev Growth | Div Yield |
|---|---|---|---|---|---|---|
| AXGNAxogen, Inc. | $2.23B | — | — | 0.39% | 23.06% | 0.00% |
| ABTAbbott Laboratories | $180.63B | 38.55x | 17.33x | — | 14.50% | 2.43% |
Subject metrics from SEC filings where available; peer metrics from cached market data.
| $122.04B |
| 23.44x |
| 13.64x |
| 4.43% |
| 13.70% |
| 3.02% |
| SYKStryker Corporation | $117.81B | 31.83x | 17.60x | 3.49% | 9.40% | 1.15% |
| BSXBoston Scientific Corporation | $66.22B | 18.50x | 13.75x | 3.70% | 7.50% | 0.00% |
| EWEdwards Lifesciences Corporation | $51.29B | 52.09x | 23.99x | 2.40% | 13.60% | 0.00% |
| GEHCGE HealthCare Technologies Inc. | $32.50B | 16.43x | 11.40x | 4.84% | 5.80% | 0.22% |
| DXCMDexCom, Inc. | $29.41B | 30.93x | 20.57x | 3.47% | 13.10% | 0.00% |
| STESTERIS plc | $22.63B | 28.38x | 14.76x | 3.53% | 7.30% | 1.11% |